Alcohol Prep Pad

Isopropyl Alcohol


Shandong Haiyan Medical Manufacture Co., Ltd.
Human Otc Drug
NDC 42339-001
Alcohol Prep Pad also known as Isopropyl Alcohol is a human otc drug labeled by 'Shandong Haiyan Medical Manufacture Co., Ltd.'. National Drug Code (NDC) number for Alcohol Prep Pad is 42339-001. This drug is available in dosage form of Swab. The names of the active, medicinal ingredients in Alcohol Prep Pad drug includes Isopropyl Alcohol - .7 mL/1 . The currest status of Alcohol Prep Pad drug is Active.

Drug Information:

Drug NDC: 42339-001
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Alcohol Prep Pad
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Isopropyl Alcohol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Shandong Haiyan Medical Manufacture Co., Ltd.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Swab
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ISOPROPYL ALCOHOL - .7 mL/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 18 Feb, 2012
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 12 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part344
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Shandong Haiyan Medical Manufacture Co., Ltd.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:797544
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:ND2M416302
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
42339-001-0115 BOX in 1 CONTAINER (42339-001-01) / 200 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-02100 BOX in 1 CONTAINER (42339-001-02) / 100 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-033000 SWAB in 1 CONTAINER (42339-001-03)01 Dec, 2017N/ANo
42339-001-04100 BOX in 1 CONTAINER (42339-001-04) / 50 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-0530 BOX in 1 CASE (42339-001-05) / 36 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-0624 BOX in 1 CASE (42339-001-06) / 50 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-0724 BOX in 1 CASE (42339-001-07) / 100 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-0820 BOX in 1 CASE (42339-001-08) / 140 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-0930 BOX in 1 CASE (42339-001-09) / 100 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-1015 BOX in 1 CASE (42339-001-10) / 200 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-1120 BOX in 1 CASE (42339-001-11) / 200 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-1212 BOX in 1 CASE (42339-001-12) / 100 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-1348 BOX in 1 CASE (42339-001-13) / 200 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-1420 BOX in 1 CASE (42339-001-14) / 200 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-1524 BOX in 1 CASE (42339-001-15) / 400 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-1620 BOX in 1 CASE (42339-001-16) / 50 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-1720 BOX in 1 CASE (42339-001-17) / 200 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-184 BOX in 1 CASE (42339-001-18) / 1000 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-1920 BOX in 1 CASE (42339-001-19) / 200 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2010 BOX in 1 CASE (42339-001-20) / 100 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2130 BOX in 1 CASE (42339-001-21) / 36 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2220 BOX in 1 CASE (42339-001-22) / 80 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2315 BOX in 1 CASE (42339-001-23) / 120 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2420 BOX in 1 CASE (42339-001-24) / 100 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2530 BOX in 1 CASE (42339-001-25) / 100 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2630 BOX in 1 CASE (42339-001-26) / 140 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2730 BOX in 1 CASE (42339-001-27) / 200 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2896 BOX in 1 CASE (42339-001-28) / 100 SWAB in 1 BOX01 Dec, 2017N/ANo
42339-001-2910 BOX in 1 CASE (42339-001-29) / 100 SWAB in 1 BOX01 Dec, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antiseptic

Product Elements:

Alcohol prep pad isopropyl alcohol water isopropyl alcohol isopropyl alcohol

Indications and Usage:

Use for preparation of skin prior to injection.

Warnings:

Warnings for external use only. flammable,keep away from fire or flame. do not use with electrocautery procedures in eyes. stop use and ask a doctor if irritation and redness develop,condition persists for more than 72 hours . keep out of reach of children in case of accidental ingestion, seek professional assistance or consult a poisoncontrol center immediately.

Dosage and Administration:

Directions wipe injection site vigorously and discard.

Package Label Principal Display Panel:

Section text here haiyan001


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.